Action on human albumin not swift enough

BMJ 1998; 317 doi: 10.1136/bmj.317.7155.367 (Published 8 August 1998)
Cite this as: BMJ 1998;317:367.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Caroline White
  1. London

    The Department of Health has dragged its feet over the findings of the Cochrane Injuries Group on human albumin, and it is not providing sufficient interim advice to doctors, according to the principal author of the group's report, Ian Roberts.

    Human albumin is used in the emergency treatment of shock, acute management of burns, and clinical situations associated with hypoprotein-aemia. A systematic review showed that albumin administration results in six extra deaths for every 100 patients treated (25 July, p 235p-40).

    Dr Roberts claims that he alerted the department to the findings in the first week of April. An emergency meeting …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL